N-Acetylcysteine Helped Adolescents Quit Marijuana Without Reducing Craving, Suggesting a Different Mechanism | Research

The takeaway

In an 8-week trial, marijuana craving decreased similarly in both N-acetylcysteine and placebo groups, even though NAC participants submitted more negative urine tests, suggesting NAC reduces marijuana use through mechanisms other than craving reduction.

Read this if you are interested in how medications might help with marijuana cessation through different pathways.

More abstinence with NAC despite equal craving reduction, suggesting a non-craving mechanism

What the researchers found

Eighty-nine adolescents were randomized to N-acetylcysteine (NAC, 1200 mg twice daily) or placebo in an 8-week marijuana cessation trial. All received contingency management and counseling. Marijuana craving, measured by the short-form Marijuana Craving Questionnaire, decreased significantly over time in both groups with no between-group difference.

However, NAC participants submitted significantly more negative urine cannabinoid tests than placebo participants (a finding from the parent trial). This dissociation, more abstinence without less craving, suggests NAC's cessation-promoting effect works through mechanisms other than craving reduction, possibly through glutamate modulation affecting habit and compulsive drug-seeking rather than the subjective desire to use.

Why it matters

Understanding how cessation medications work matters for treatment optimization. If NAC reduces use without reducing craving, it may work by interrupting automatic, habitual drug-seeking behavior rather than by reducing the conscious desire to use. This mechanistic insight could inform combination treatment approaches.

The numbers in context

89 adolescents. NAC 1200 mg twice daily for 8 weeks. Craving decreased similarly in both groups (no between-group difference). NAC group: significantly more negative urine tests. Mechanism: not craving reduction.

How the study worked

Secondary analysis of an 8-week, double-blind, placebo-controlled trial. 89 adolescents (NAC n=45, placebo n=44). All received contingency management and cessation counseling. Marijuana Craving Questionnaire-Short Form measured at multiple timepoints.

What this study cannot tell us

Secondary analysis of a small trial. The craving measure may not capture all aspects of desire to use. Contingency management (paid for negative urine tests) could have influenced both craving and use independently. The mechanism is inferred, not directly tested.

How to read the evidence

Controlled trial with appropriate analysis; moderate evidence for a mechanistic insight about NAC.

When this study was published

Published in 2013. NAC for cannabis use disorder continues to be studied.

The bigger picture

This study illustrates an important concept in addiction treatment: abstinence and craving can be dissociated. Drug use is not driven solely by craving; habit, compulsion, and environmental cues also drive use. NAC may target these non-craving pathways through its effects on glutamate, the brain's main excitatory neurotransmitter.

Questions still open

Would combining NAC with a craving-reducing medication produce additive effects? Does NAC work by normalizing glutamate in specific brain circuits? Would the dissociation between craving and use persist after contingency management is removed?

Common questions

Does NAC reduce marijuana craving?

No. In this trial, marijuana craving decreased equally in both the NAC and placebo groups. However, the NAC group achieved more abstinence (negative urine tests). This means NAC appears to help people use less marijuana through some mechanism other than reducing the conscious desire to use.

How might NAC help with marijuana use without reducing craving?

NAC is known to modulate glutamate, the brain's main excitatory neurotransmitter. Addiction involves both conscious craving and automatic, habitual drug-seeking behavior. NAC may work by normalizing the glutamate circuits involved in compulsive behavior and habit formation, allowing people to interrupt their use patterns even when craving remains present.

Read the original research

Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.

Addictive behaviors, 38(3), 1788-91

View on PubMed ↗Publisher’s paper ↗

Citation

Roten, Amanda T; Baker, Nathaniel L; Gray, Kevin M. (2013). Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.. Addictive behaviors, 38(3), 1788-91. https://doi.org/10.1016/j.addbeh.2012.11.003